Related Experiment Video
Updated: Apr 12, 2026
04:21
A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
Published on: August 4, 2021
7.4K
Neonatal medicines research: challenges and opportunities
Janko Samardzic1, Mark A Turner, Ralph Bax
1University of Belgrade, Institute of Pharmacology, Clinical Pharmacology and Toxicology, Medical Faculty, Belgrade, Serbia.
Expert Opinion on Drug Metabolism & Toxicology
|May 12, 2015
Summary
Neonatal drug research faces challenges due to rapid maturation and variability. Innovative tools like dried blood spots and micro-dosing, alongside research networks, improve neonatal pharmacotherapy knowledge.
Area of Science:
- Neonatal pharmacology and clinical research.
Background:
- Neonates exhibit rapid age-dependent maturation, leading to significant pharmacokinetic and pharmacodynamic variability.
- This variability is further complicated by factors such as treatment, environment, and genetics, making research challenging.
Purpose of the Study:
- To address the challenges in neonatal clinical research.
- To highlight the need for tailored research tools and enhanced research networks for neonates.
Main Methods:
- Development and application of dried blood spot techniques.
- Introduction of micro-dosing and micro-tracer methodologies in neonatal drug studies.
- Integration of sparse sampling with population modeling.
Main Results:
- Dried blood spot and micro-dosing techniques facilitate neonatal drug studies.
- Population modeling combined with sparse sampling enables robust data analysis.
- Dedicated working groups and agency initiatives are building knowledge on neonatal pharmacotherapy.
Conclusions:
- Challenges in neonatal medicine research are surmountable with tailored tools and strategic trial design.
- Improved understanding of neonatal pharmacotherapy requires collaboration among researchers, sponsors, regulators, and patient representatives.
- Legal initiatives and collaborative efforts are crucial for advancing neonatal drug research.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
389
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
829
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
499
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
353
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
353
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K